Sensorion SA

EPA:ALSEN.PA

0.91 (EUR) • At close September 19, 2024
Bedrijfsnaam Sensorion SA
Symbool ALSEN.PA
Munteenheid EUR
Prijs 0.908
Beurswaarde 288,293,025
Dividendpercentage 0%
52-weken bereik 0.403 - 1.04
Industrie Biotechnology
Sector Healthcare
CEO Ms. Nawal Ouzren
Website https://www.sensorion.com

An error occurred while fetching data.

Over Sensorion SA

Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type

Vergelijkbare Aandelen

Hybrigenics SA logo

Hybrigenics SA

ALHYG.PA

0.01 EUR

Theraclion SA logo

Theraclion SA

ALTHE.PA

0.397 EUR

genOway Société anonyme logo

genOway Société anonyme

ALGEN.PA

3.8 EUR

SpineGuard SA logo

SpineGuard SA

ALSGD.PA

0.13 EUR

Ikonisys S.A. logo

Ikonisys S.A.

ALIKO.PA

1.7 EUR

Adocia SA logo

Adocia SA

ADOC.PA

5.5 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)